Berthold Hackl is an accomplished professional with extensive experience in the healthcare and medical device sectors. Currently, Hackl serves as a Board Member at Neurescue, where efforts are focused on innovative treatments for cardiac arrest. Additionally, Hackl is a Strategic Partner at ArchiMed, a firm dedicated to healthcare investments. Other prominent roles include Chairman at Human Med AG and Chairperson of the Board at both Arthro Kinetics AG and Minitube International AG. Hackl is also a Board Member at Groupe CARSO and PlasmidFactory GmbH & Co. KG, alongside serving as a Senior Advisor at Back Bay Life Science Advisors and managing Sorrento Investment GmbH. Hackl's academic background includes an MBA from INSEAD and a Diploma in Molecular Biology from The University of Freiburg.
This person is not in any teams
This person is not in any offices